MPH Health Care Future Growth
Future criteria checks 0/6
MPH Health Care's revenue and earnings are forecast to decline at 60.2% and 65.7% per annum respectively while EPS is expected to decline by 152.5% per annum.
Key information
-65.7%
Earnings growth rate
-152.5%
EPS growth rate
| Pharmaceuticals earnings growth | 21.5% |
| Revenue growth rate | -60.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Oct 2024 |
Recent future growth updates
Recent updates
If You Had Bought MPH Health Care's (ETR:93M) Shares A Year Ago You Would Be Down 28%
Aug 10
What Type Of Returns Would MPH Health Care's(ETR:93M) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Aug 10We Think MPH Health Care's (ETR:93M) Statutory Profit Might Understate Its Earnings Potential
Jul 06
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 43 | 39 | 12 | -2 | 1 |
| 12/31/2024 | 81 | 76 | 11 | -3 | 1 |
| 6/30/2024 | 118 | 119 | -1 | -1 | N/A |
| 3/31/2024 | 76 | 75 | -2 | -2 | N/A |
| 12/31/2023 | 34 | 30 | -2 | -2 | N/A |
| 9/30/2023 | 33 | 40 | -1 | -1 | N/A |
| 6/30/2023 | 31 | 50 | -1 | -1 | N/A |
| 3/31/2023 | 31 | 39 | 0 | 0 | N/A |
| 12/31/2022 | 31 | 29 | 0 | 0 | N/A |
| 9/30/2022 | 10 | -20 | -1 | -1 | N/A |
| 6/30/2022 | -11 | -68 | -1 | -1 | N/A |
| 3/31/2022 | 1 | -39 | -1 | -1 | N/A |
| 12/31/2021 | 14 | -9 | -1 | -1 | N/A |
| 9/30/2021 | 18 | -12 | -1 | -1 | N/A |
| 6/30/2021 | 22 | -14 | -1 | -1 | N/A |
| 3/31/2021 | 13 | -42 | -2 | -2 | N/A |
| 12/31/2020 | 3 | -70 | -3 | -3 | N/A |
| 9/30/2020 | 20 | -37 | -2 | -2 | N/A |
| 6/30/2020 | 38 | -3 | -1 | -1 | N/A |
| 3/31/2020 | 39 | 4 | -1 | -1 | N/A |
| 12/31/2019 | 41 | 11 | -1 | -1 | N/A |
| 9/30/2019 | 19 | -13 | 0 | 0 | N/A |
| 6/30/2019 | -3 | -37 | 1 | 1 | N/A |
| 3/31/2019 | 21 | 0 | 3 | 3 | N/A |
| 12/31/2018 | 45 | 37 | 5 | 5 | N/A |
| 9/30/2018 | 64 | 63 | 1 | 1 | N/A |
| 6/30/2018 | 84 | 90 | -2 | -2 | N/A |
| 3/31/2018 | 59 | 61 | N/A | -1 | N/A |
| 12/31/2017 | 34 | 32 | N/A | 1 | N/A |
| 9/30/2017 | 22 | 45 | N/A | 0 | N/A |
| 6/30/2017 | 10 | 58 | N/A | 0 | N/A |
| 3/31/2017 | 10 | 69 | N/A | -3 | N/A |
| 12/31/2016 | 9 | 80 | N/A | -5 | N/A |
| 9/30/2016 | 83 | 90 | N/A | -2 | N/A |
| 6/30/2016 | 156 | 100 | N/A | 1 | N/A |
| 3/31/2016 | 210 | 91 | N/A | 1 | N/A |
| 12/31/2015 | 263 | 83 | N/A | 0 | N/A |
| 9/30/2015 | 239 | 43 | N/A | 1 | N/A |
| 6/30/2015 | 214 | 3 | N/A | 3 | N/A |
| 3/31/2015 | 217 | 4 | N/A | 1 | N/A |
| 12/31/2014 | 219 | 5 | N/A | 0 | N/A |
| 9/30/2014 | 226 | 6 | N/A | -3 | N/A |
| 6/30/2014 | 232 | 7 | N/A | -6 | N/A |
| 3/31/2014 | 229 | 7 | N/A | -5 | N/A |
| 12/31/2013 | 227 | 6 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 93M1's earnings are forecast to decline over the next 3 years (-65.7% per year).
Earnings vs Market: 93M1's earnings are forecast to decline over the next 3 years (-65.7% per year).
High Growth Earnings: 93M1's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 93M1's revenue is expected to decline over the next 3 years (-60.2% per year).
High Growth Revenue: 93M1's revenue is forecast to decline over the next 3 years (-60.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 93M1's Return on Equity is forecast to be high in 3 years time